Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (321-330 of 506) with videos related to

Pageof 51
Sort By:
Arthritis Research & Therapy|February 20, 2020
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosisEmmanuel Ledoult, David Launay, Hélène Béhal, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Journal of Translational Autoimmunity|January 23, 2023
COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infectionCloé Comarmond, Elodie Drumez, Julien Labreuche, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2026
Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR databaseCorrado Campochiaro, Marie-Elise Truchetet, Madelon Vonk, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|October 4, 2021
Ludovic Trefond, Elodie Drumez, Marc Andre, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Joint Bone Spine|May 29, 2021
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseasesLudovic Trefond, Elodie Drumez, Marc Andre, et al.
American Journal of Nephrology|January 17, 2022
Early Renal Recovery after the First Flare of Pauci-Immune GlomerulonephritisJérémy Zaworski, Viviane Gnemmi, Pierre Bataille, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 25, 2024
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological DataYann Nguyen, Maxime Beydon, Jacques-Eric Gottenberg, et al.
Journal of Autoimmunity|March 4, 2025
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Frédérique Aubourg, et al.
Pageof 51

Showing results (321-330 of 506) with videos related to

Sort By:
Pageof 51
Arthritis Research & Therapy|February 20, 2020
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosisEmmanuel Ledoult, David Launay, Hélène Béhal, et al.
Rheumatology (Oxford, England)|March 3, 2022
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experimentCosimo Bruni, Sebastian Heidenreich, Ashley Duenas, et al.
Journal of Translational Autoimmunity|January 23, 2023
COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infectionCloé Comarmond, Elodie Drumez, Julien Labreuche, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2026
Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR databaseCorrado Campochiaro, Marie-Elise Truchetet, Madelon Vonk, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|October 4, 2021
Ludovic Trefond, Elodie Drumez, Marc Andre, et al.
The Lancet. Rheumatology|January 30, 2024
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 studyDominique Farge, Séverine Loisel, Matthieu Resche-Rigon, et al.
Joint Bone Spine|May 29, 2021
Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseasesLudovic Trefond, Elodie Drumez, Marc Andre, et al.
American Journal of Nephrology|January 17, 2022
Early Renal Recovery after the First Flare of Pauci-Immune GlomerulonephritisJérémy Zaworski, Viviane Gnemmi, Pierre Bataille, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 25, 2024
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological DataYann Nguyen, Maxime Beydon, Jacques-Eric Gottenberg, et al.
Journal of Autoimmunity|March 4, 2025
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort StudyBenjamin Chaigne, Alexandre Bense, Frédérique Aubourg, et al.
Pageof 51